04734nam 2200613Ia 450 991046146680332120200520144314.01-61761-167-0(CKB)2670000000150170(EBL)3017989(SSID)ssj0000694155(PQKBManifestationID)11368968(PQKBTitleCode)TC0000694155(PQKBWorkID)10667230(PQKB)11551206(MiAaPQ)EBC3017989(Au-PeEL)EBL3017989(CaPaEBR)ebr10658911(OCoLC)775352327(EXLCZ)99267000000015017020100625d2011 uy 0engur|n|---|||||txtccrVentricular fibrillation and acute coronary syndrome[electronic resource] /editor, Joyce E. MandellHauppauge, NY Nova Science20111 online resource (248 p.)Cardiology research and clinical developmentsDescription based upon print version of record.1-61728-969-8 Includes bibliographical references and index.""VENTRICULAR FIBRILLATION AND ACUTE CORONARY SYNDROME""; ""VENTRICULAR FIBRILLATION AND ACUTE CORONARY SYNDROME""; ""CONTENTS ""; ""PREFACE""; ""CLOPIDOGREL RESPONSE IN ACUTE CORONARY SYNDROME: CLINICAL IMPLICATIONS AND EMERGING THERAPIES ""; ""ABSTRACT ""; ""ABBREVIATIONS LIST ""; ""INTRODUCTION ""; ""RESISTANCE/VARIABLE RESPONSE TO CLOPIDOGREL. DOES IT EXIST? ""; ""MECHANISMS OF VARIABLE RESPONSE TO CLOPIDOGREL ""; ""Genetic Polymorphism ""; ""Drug-Drug Interactions ""; ""Statins ""; ""Proton Pump Inhibitors ""; ""Calcium-Channel Blockers """"IS IT POSSIBLE TO ACCURATELY ASSESS THE INHIBITORY EFFECT OF ANTIPLATELT DRUGS? """"CLINICAL IMPLICATIONS OF VARIABLE RESPONSE TO CLOPIDOGREL ""; ""Drug Eluting Stent""; ""WHAT TO DO WITH PATIENTS WITH REDUCED RESPONSE TO CLOPIDOGREL THERAPY? ""; ""Optimise Clopidogrel Response According to Platelet Function Tests ""; ""EMERGING THERAPIES ""; ""Prasugrel ""; ""Ticagrelor ""; ""Cangrelor ""; ""REFERENCES ""; ""PROTEOMICS OF ACUTE CORONARY SYNDROME ""; ""1. INTRODUCTION ""; ""2. PLASMA ""; ""3. BLOOD CELLS IN ACUTE CORONARY SYNDROME ""; ""3.1. Circulating Monocytes ""; ""3.2 Platelets """"3.3. Proteomics on Vascular Progenitors """"Endothelial Progenitor Cells (EPC) ""; ""4. TISSUE PROTEOMICS ""; ""Secretome ""; ""5. METABOLOMICS""; ""ABBREVIATIONS""; ""PROTEINS ABBREVIATIONS ""; ""REFERENCES ""; ""MAJOR BLEEDING IN ACUTE CORONARY SYNDROME: DEFINITIONS, MAGNITUDE OF THE PROBLEM, PREDICTORS, OUTCOMES, MANAGEMENT, AND PREVENTION ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""DEFINITIONS OF MAJOR BLEEDING IN ACS ""; ""MAGNITUDE OF THE PROBLEM ""; ""PREDICTORS OF MAJOR BLEEDING ""; ""Age ""; ""Gender ""; ""History of Bleeding ""; ""Renal Impairment ""; ""Type of ACS """"Killip Class """"Diabetes Mellitus ""; ""Choice of Antiplatelet, Antithrombotic, and Fibrinolytic Agents""; ""Invasive Procedures ""; ""Blood Transfusion ""; ""Anemia ""; ""HOSPITAL OUTCOMES AND MAJOR BLEEDING ""; ""Mechanisms by Which Major Bleeding Affects Outcomes ""; ""Prevention and Management ""; ""CONCLUSION ""; ""REFERENCES""; ""NOVEL ANTIPLATELETS IN ACUTE CORONARY SYNDROMES ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""ASPIRIN (ACETYLSALICYLIC ACID, ASA) ""; ""THIENOPYRIDINES ""; ""Ticlopidine ""; ""Clopidogrel ""; ""Prasugrel ""; ""Cangrelor (ARC-69931MX) ""; ""Ticagrelor (AZD6140) """"Elinogrel """"Bx667 ""; ""THROMBOXANE RECEPTOR ANTAGONISTS ""; ""Terutroban (S18886) ""; ""von Willebrand Factor Inhibitors ""; ""Ajw200 ""; ""Arc1779 ""; ""Alx-0081 ""; ""DIRECT THROMBIN INHIBITORS (PAR-1 INHIBITORS) ""; ""Sch 530348 ""; ""E5555 ""; ""CONCLUSION ""; ""REFERENCES ""; ""UNCONTROLLED IMMUNE RESPONSE IN ACUTE MYOCARDIAL INFARCTION ""; ""ABSTRACT""; ""INTRODUCTION ""; ""LEUKOCYTES ""; ""NEUTROPHILS ""; ""MONOCYTES ""; ""LYMPHOCYTES ""; ""Rationale and Clinical Evidence ""; ""Effector T-Cells ""; ""Regulatory T-Cells ""; ""The Inverted Pyramid Model """"THERAPEUTIC OPPORTUNITIES ""Cardiology research and clinical developments.Coronary heart diseaseVentricular fibrillationElectronic books.Coronary heart disease.Ventricular fibrillation.616.1/23Mandell Joyce E968729MiAaPQMiAaPQMiAaPQBOOK9910461466803321Ventricular fibrillation and acute coronary syndrome2200406UNINA